Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Ingelsson

Showing results (151-160 of 217) with videos related to

Pageof 22
Sort By:
Journal of Translational Medicine|April 20, 2023
Size matters: the impact of nucleus size on results from spatial transcriptomicsElyas Mohammadi, Katarzyna Chojnowska, Michał Bieńkowski, et al.
Proteomics. Clinical Applications|September 9, 2016
CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's diseaseJulia Remnestål, David Just, Nicholas Mitsios, et al.
Acta Neuropathologica Communications|November 5, 2025
α-Synuclein purification significantly impacts seed amplification assay performance and consistencyZaid A M Al-Azzawi, Nicholas R G Silver, Surabhi Mehra, et al.
American Journal of Human Genetics|May 28, 2016
Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer DiseaseJan P Dumanski, Jean-Charles Lambert, Chiara Rasi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 25, 2025
Distinct inflammatory profiles in young-onset versus late-onset Alzheimer's diseaseSimrika Thapa, Chloe Anastassiadis, Anna Vasilevskaya, et al.
Molecular Therapy. Nucleic Acids|May 4, 2022
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease <i>PSEN</i> <i>1</i> M146L mutationEvangelos Konstantinidis, Agnieszka Molisak, Florian Perrin, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's DiseaseBence György, Camilla Lööv, Mikołaj P Zaborowski, et al.
Neurobiology of Aging|August 3, 2010
Engulfment adapter PTB domain containing 1 interacts with and affects processing of the amyloid-β precursor proteinAnja-Silke Beyer, Bjoern von Einem, Daniel Schwanzar, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2010
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analysesNoel G Faux, Craig W Ritchie, Adam Gunn, et al.
Acta Neuropathologica Communications|November 21, 2013
The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated AβHannu Kalimo, Maciej Lalowski, Nenad Bogdanovic, et al.
Pageof 22

Showing results (151-160 of 217) with videos related to

Sort By:
Pageof 22
Journal of Translational Medicine|April 20, 2023
Size matters: the impact of nucleus size on results from spatial transcriptomicsElyas Mohammadi, Katarzyna Chojnowska, Michał Bieńkowski, et al.
Proteomics. Clinical Applications|September 9, 2016
CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's diseaseJulia Remnestål, David Just, Nicholas Mitsios, et al.
Acta Neuropathologica Communications|November 5, 2025
α-Synuclein purification significantly impacts seed amplification assay performance and consistencyZaid A M Al-Azzawi, Nicholas R G Silver, Surabhi Mehra, et al.
American Journal of Human Genetics|May 28, 2016
Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer DiseaseJan P Dumanski, Jean-Charles Lambert, Chiara Rasi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 25, 2025
Distinct inflammatory profiles in young-onset versus late-onset Alzheimer's diseaseSimrika Thapa, Chloe Anastassiadis, Anna Vasilevskaya, et al.
Molecular Therapy. Nucleic Acids|May 4, 2022
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease <i>PSEN</i> <i>1</i> M146L mutationEvangelos Konstantinidis, Agnieszka Molisak, Florian Perrin, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's DiseaseBence György, Camilla Lööv, Mikołaj P Zaborowski, et al.
Neurobiology of Aging|August 3, 2010
Engulfment adapter PTB domain containing 1 interacts with and affects processing of the amyloid-β precursor proteinAnja-Silke Beyer, Bjoern von Einem, Daniel Schwanzar, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2010
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analysesNoel G Faux, Craig W Ritchie, Adam Gunn, et al.
Acta Neuropathologica Communications|November 21, 2013
The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated AβHannu Kalimo, Maciej Lalowski, Nenad Bogdanovic, et al.
Pageof 22